13 results
424B5
IKT
Inhibikase Therapeutics Inc
22 May 24
Prospectus supplement for primary offering
8:55am
., mostly in women between the ages of 30 and 60. The global PAH market size was valued at $7.66 billion in 2023 and is estimated to grow
8-K
EX-99.1
IKT
Inhibikase Therapeutics Inc
30 Apr 24
Regulation FD Disclosure
8:17am
of Parkinson’s disease Co-morbid indications MSA has no beneficial Men twice treatments as likely as The country with the highest women to diagnosed
8-K
EX-99.1
6kdk 31sm1vgqn2iv8w
15 Aug 22
Regulation FD Disclosure
5:12pm
8-K
EX-99.1
x1bjtkmibys74w22o
21 Apr 22
Regulation FD Disclosure
4:19pm
8-K
EX-99.1
y6fv52
20 Jan 22
Clinical Development of Therapies Intended to Reverse the Functional Loss in Parkinson’s and Related Disorders 1Q 2022 BUSINESS PRESENTATION IKT
4:10pm
8-K
EX-99.1
8bz22 j9g
19 Oct 21
Clinical Development of Therapies Intended to Reverse the Functional Loss in Parkinson’s and Related Disorders 4Q 2021 BUSINESS PRESENTATION IKT
5:03pm
8-K
EX-99.1
pnthkgac2flo9m
17 Aug 21
Regulation FD Disclosure
5:02pm
8-K
EX-99.1
jwdi 4kxww42b273
1 Jun 21
Regulation FD Disclosure
7:30am
- Prev
- 1
- Next